Applicants,Chemical_Name,Funding_requested_for,Pharmaceutical,Priority_List,Schedules,Therapeutic_group
Sanofi,Insulin Glargine - Long Acting,Type 1 diabetes,Insulin Glargine - Long Acting,Only if cost neutral or cost saving,,Alimentary Tract and Metabolism
